Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Cancer"
DOI: 10.1038/s41416-018-0318-0
Abstract: BackgroundOptimising the selection of HER2-targeted regimens by identifying subsets of HER2-positive breast cancer (BC) patients who need more or less therapy remains challenging. We analysed BC samples before and after treatment with 1 cycle of… read more here.
Keywords: single agent; her2 positive; agent trastuzumab; treatment ... See more keywords
Male Accessory Breast Cancer Successfully Treated With Single-Agent Trastuzumab: A Case Report
Sign Up to like & getrecommendations! Published in 2023 at "American Journal of Men's Health"
DOI: 10.1177/15579883231171010
Abstract: Male accessory breast cancer is an extremely rare tumor. There is no report about its monotherapy and subsequent outcome prior to 2022. The current study presents the case of a 76-year-old male patient with a… read more here.
Keywords: single agent; breast; accessory breast; agent trastuzumab ... See more keywords